D Pharm
Rehovot
About D Pharm
D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions. The Company’s particular area of interest is in developing innovative medicine for degenerative and age-related disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $100K – $500K
- Total funding: $37.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2015)
- Ticker: tlv:DPRM
- Website: dpharm.com
- Phone: +97289385100
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/d-pharm-590924 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.